Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri, Jason E. Farrar, Timothy J. Triche, et al.
Nature Medicine (2017) Vol. 24, Iss. 1, pp. 103-112
Open Access | Times Cited: 686

Showing 1-25 of 686 citing articles:

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma, Yu Liu, Yanling Liu, et al.
Nature (2018) Vol. 555, Iss. 7696, pp. 371-376
Open Access | Times Cited: 790
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 468
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Robert L. Bowman, Lambert Busque, Ross L. Levine
Cell stem cell (2018) Vol. 22, Iss. 2, pp. 157-170
Open Access | Times Cited: 408
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Thomas Alexander, Zhaohui Gu, Ilaria Iacobucci, et al.
Nature (2018) Vol. 562, Iss. 7727, pp. 373-379
Open Access | Times Cited: 306
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen, Yue Sheng, Allen Zhu, et al.
Cell stem cell (2020) Vol. 27, Iss. 1, pp. 64-80.e9
Open Access | Times Cited: 297
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers
Eric J. Duncavage, Molly C. Schroeder, Michele O’Laughlin, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 10, pp. 924-935
Open Access | Times Cited: 224
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G.X. Zeng, Suraj Bansal, Liqing Jin, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1212-1223
Open Access | Times Cited: 196
The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
E. Alejandro Sweet‐Cordero, Jaclyn A. Biegel
Science (2019) Vol. 363, Iss. 6432, pp. 1170-1175
Open Access | Times Cited: 181
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 546
Open Access | Times Cited: 171
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 137
Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia
Lindsey E. Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2846-2867
Open Access | Times Cited: 131
Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
Bappaditya Chandra, Nicole L. Michmerhuizen, Hazheen K. Shirnekhi, et al.
Cancer Discovery (2021) Vol. 12, Iss. 4, pp. 1152-1169
Open Access | Times Cited: 114
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Joo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2487-2502.e13
Open Access | Times Cited: 110
A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer
Pierina Cetraro, Julio Plaza‐Díaz, Alex MacKenzie, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1671-1671
Open Access | Times Cited: 78
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 18, pp. 2023-2035
Open Access | Times Cited: 77
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Antonella Padella, Andrea Ghelli Luserna di Rorà, Giovanni Marconi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 71
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia
Marie Sébert, Stéphanie Gachet, Thierry Leblanc, et al.
Cell stem cell (2023) Vol. 30, Iss. 2, pp. 153-170.e9
Open Access | Times Cited: 50
A new genomic framework to categorize pediatric acute myeloid leukemia
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Nature Genetics (2024) Vol. 56, Iss. 2, pp. 281-293
Open Access | Times Cited: 37
Pathophysiology of Acute Myeloid Leukemia
Franziska Wachter, Yana Pikman
Acta Haematologica (2024) Vol. 147, Iss. 2, pp. 229-246
Closed Access | Times Cited: 17
The Role of Chronic Inflammation in Pediatric Cancer
Christine Mella, Panogiotis Tsarouhas, Maximillian Brockwell, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 154-154
Open Access | Times Cited: 2
FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
Vanessa E. Kennedy, Catherine C. Smith
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 137
Genomic subtyping and therapeutic targeting of acute erythroleukemia
Ilaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.
Nature Genetics (2019) Vol. 51, Iss. 4, pp. 694-704
Open Access | Times Cited: 135
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome
Maurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 123-138.e10
Open Access | Times Cited: 123
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group
Richard Aplenc, Soheil Meshinchi, Lillian Sung, et al.
Haematologica (2020) Vol. 105, Iss. 7, pp. 1879-1886
Open Access | Times Cited: 121
Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
John M. Perry, Tao Fang, Anuradha Roy, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 6, pp. 689-700
Open Access | Times Cited: 112
Page 1 - Next Page

Scroll to top